Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00463099 · ClinicalTrials.gov registry record
Multicenter Orthopaedics Outcomes Network for ACL Reconstructions
A clinical trial of Rupture of Anterior Cruciate Ligament, sponsored by Vanderbilt University Medical Center.
- Active
- Registry status
- 3,294
- Enrollment target
- 8
- Study locations
NCT00463099: Active study of Rupture of Anterior Cruciate Ligament, sponsored by Vanderbilt University Medical Center.
NCT00463099 is a study of Rupture of Anterior Cruciate Ligament that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 3,294 participants. The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00463099, a study of Rupture of Anterior Cruciate Ligament, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 3,294 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to determine the effect of modifiable risk factors on knee function, osteoarthritis, and re-rupture of the anterior cruciate ligament (ACL) following ACL reconstruction.
Primary Outcome
Sports function (as measured by the KOOS and IKDC). Activity level (as measured by the Marx activity rating scale). General health (as measured by the SF-36).
Conditions Studied
Study Locations (8)
Ohio
- Cleveland Clinic - Cleveland
- The Ohio State University - Columbus
Colorado
- University of Colorado - Boulder
Iowa
- University of Iowa - Iowa City
Missouri
- Washington University at St. Louis - St Louis
New York
- Hospital for Special Surgery - New York
North Carolina
- Duke University - Durham
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,294 participants |
| Start Date | 2002-01 |
| Est. Completion | 2028-12 |
What the registry record for NCT00463099 still lists
NCT00463099 is an observational study that tracks outcomes without assigning an intervention. Its 3,294 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Rupture of Anterior Cruciate Ligament appearing as the primary indexed condition, and to 0 interventions.
NCT00463099 lists 8 locations in 7 states (Ohio, Colorado, Iowa).
Frequently Asked Questions
What is clinical trial NCT00463099 about?
NCT00463099 is a clinical study titled "Multicenter Orthopaedics Outcomes Network for ACL Reconstructions". The purpose of this study is to determine the effect of modifiable risk factors on knee function, osteoarthritis, and re-rupture of the anterior cruciate ligament (ACL) following ACL reconstruction.
What is the current status of trial NCT00463099?
This trial is currently active not recruiting. The enrollment target is 3,294 participants. The study started on 2002-01. Estimated completion is 2028-12.
What conditions does trial NCT00463099 study?
This clinical trial studies the following conditions: Rupture of Anterior Cruciate Ligament.
Who is sponsoring clinical trial NCT00463099?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00463099 being conducted?
This trial has 8 study locations across Colorado, Iowa, Missouri, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rupture of Anterior Cruciate Ligament
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06815536 · 3,291 participants
Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae
- NCT06543446 · 3,290 participants · NA
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy
- NCT07214610 · 3,300 participants · NA
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
- NCT03674307 · 3,306 participants · NA
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia